Ensysce Biosciences | D: Filing D
Feb 21 11:42 ET
Ensysce Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lincoln Park Capital Fund, LLC(3.792%),Lincoln Park Capital, LLC(3.792%), etc.
Feb 14 16:39 ET
Ensysce Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bob G. Gower(5.7%)
Jul 17, 2023 18:15 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities-Director GOWER BOB G
Mar 6, 2023 16:33 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities-Director GOWER BOB G
Mar 2, 2023 15:45 ET
Ensysce Biosciences | D: Filing D
Mar 1, 2023 10:33 ET
Ensysce Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-HG Vora Capital Management, LLC(2.1%)
Feb 14, 2023 17:21 ET
Ensysce Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(4.9%),Heights Capital Management, Inc.(4.9%)
Feb 14, 2023 11:20 ET
Ensysce Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lincoln Park Capital Fund, LLC(9.99%),Lincoln Park Capital, LLC(9.99%), etc.
Feb 6, 2023 18:34 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Feb 1, 2023 18:06 ET
Ensysce Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-CVI Investments, Inc.(7.8%),Heights Capital Management, Inc.(7.8%)
Dec 16, 2022 10:24 ET
Ensysce Biosciences | D: Filing D
Jul 8, 2022 17:30 ET
Ensysce Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matthews Lane Capital Partners LLC(7.9%),Daniel B. Silvers(7.9%), etc.
Jul 7, 2022 09:08 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:47 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:44 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:41 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:40 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:38 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:38 ET
Ensysce Biosciences | 4: Statement of changes in beneficial ownership of securities
Jun 27, 2022 17:35 ET
No Data
No Data